Our Research Team
Cancer drugs are prone to cause varying degrees of side effects in patients, and there could be differences between the rates of these side effects between people of different ethnic groups. Understanding the reasons for these differences through detailed analysis of drug levels and their effects will provide strategies to minimise side effects. The group has performed many of such studies that have benefitted our patients.
Benefits of our research
Our research group is now recognised as a leading centre for early phase studies on cancer drugs. Early phase studies involve the use of newer novel drugs that provide alternative treatment options for patients. In a study carried out by Dr Goh BC involving he first-in-man usage of Linifanib , various patients experienced significant and proling disease control where previous treatments have failed.
90 stomach cancer patients wanted for clinical trial
Source: The Straits Times (02 August 2011)
SCIENTISTS here are recruiting stomach cancer patients for a clinical trial that may change the way the cancer is treated. They have identified two main types of this cancer, and believe customising the treatment to the cancer type can improve the patient’s chance of survival and quality of life. They are looking for 90 patients newly diagnosed with Stage 4 of this cancer and who have not had chemotherapy. Participants in the trial will get four rounds of treatment free; the remaining rounds may be subsidised. The trial, expected to last until 2013, is run by the Singapore Gastric Cancer Consortium (SGCC), which comprises scientists and doctors from local universities, hospitals and cancer and research bodies.
Read more ...New vaccine for gastric cancer being tested here
Source: The Straits Time (22 June 2011)
GASTRIC cancer patients may need just a few jabs to suppress their cancer – rather than go through arduous chemotherapy treatment – if a new cancer vaccine proves to be effective.
Read more ...
